{"id":"https://openalex.org/W7202364088","doi":"https://doi.org/10.5582/ddt.2026.01051","title":"Enlicitide: The first oral PCSK9 inhibitor approved for treatment of hypercholesterolemia","display_name":"Enlicitide: The first oral PCSK9 inhibitor approved for treatment of hypercholesterolemia","publication_year":2026,"publication_date":"2026-08-13","ids":{"openalex":"https://openalex.org/W7202364088","doi":"https://doi.org/10.5582/ddt.2026.01051","pmid":"https://pubmed.ncbi.nlm.nih.gov/42604807"},"language":"en","primary_location":{"id":"doi:10.5582/ddt.2026.01051","doi":"https://doi.org/10.5582/ddt.2026.01051","is_oa":true,"landing_page_url":"https://doi.org/10.5582/ddt.2026.01051","pdf_url":"https://www.jstage.jst.go.jp/article/ddt/advpub/0/advpub_2026.01051/_pdf","source":{"id":"https://openalex.org/S2764561415","display_name":"Drug Discoveries & Therapeutics","issn_l":"1881-7831","issn":["1881-7831","1881-784X"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-70","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discoveries & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/ddt/advpub/0/advpub_2026.01051/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5144373112","display_name":"Yueyi Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108688024","display_name":"Qingdao University","ror":"https://ror.org/021cj6z65","country_code":"CN","type":"education","lineage":["https://openalex.org/I108688024"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yueyi Sun","raw_affiliation_strings":["Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China","institution_ids":["https://openalex.org/I108688024"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069915515","display_name":"Jianjun Gao","orcid":"https://orcid.org/0000-0001-6138-4472","observed_orcids":["https://orcid.org/0000-0001-6138-4472"]},"institutions":[{"id":"https://openalex.org/I108688024","display_name":"Qingdao University","ror":"https://ror.org/021cj6z65","country_code":"CN","type":"education","lineage":["https://openalex.org/I108688024"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jianjun Gao","raw_affiliation_strings":["Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China","institution_ids":["https://openalex.org/I108688024"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I108688024"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.62674032,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"4","first_page":"354","last_page":"356"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.9309999942779541},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9490000009536743},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.8659999966621399},{"id":"https://openalex.org/keywords/atherosclerotic-cardiovascular-disease","display_name":"atherosclerotic cardiovascular disease","score":0.8700000047683716},{"id":"https://openalex.org/keywords/macrocyclic-peptides","display_name":"macrocyclic peptides","score":0.6729999780654907},{"id":"https://openalex.org/keywords/hepatic-ldl-receptor","display_name":"hepatic LDL receptor","score":0.7860000133514404},{"id":"https://openalex.org/keywords/statin-resistant-hypercholesterolemia","display_name":"statin-resistant hypercholesterolemia","score":0.7229999899864197},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.6330000162124634},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.49900001287460327}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7207000255584717},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.6244000196456909},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4077000021934509},{"id":"https://openalex.org/C2778114629","wikidata":"https://www.wikidata.org/wiki/Q15623825","display_name":"Evolocumab","level":5,"score":0.3986999988555908},{"id":"https://openalex.org/C2778824825","wikidata":"https://www.wikidata.org/wiki/Q7250439","display_name":"Proprotein convertase","level":5,"score":0.37599998712539673},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33820000290870667},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.29899999499320984},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2809000015258789},{"id":"https://openalex.org/C2778849439","wikidata":"https://www.wikidata.org/wiki/Q6397985","display_name":"Kexin","level":5,"score":0.2581999897956848},{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.24889999628067017}],"mesh":[{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000091362","descriptor_name":"PCSK9 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5582/ddt.2026.01051","doi":"https://doi.org/10.5582/ddt.2026.01051","is_oa":true,"landing_page_url":"https://doi.org/10.5582/ddt.2026.01051","pdf_url":"https://www.jstage.jst.go.jp/article/ddt/advpub/0/advpub_2026.01051/_pdf","source":{"id":"https://openalex.org/S2764561415","display_name":"Drug Discoveries & Therapeutics","issn_l":"1881-7831","issn":["1881-7831","1881-784X"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-70","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discoveries & Therapeutics","raw_type":"journal-article"},{"id":"pmid:42604807","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42604807","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug discoveries & therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.5582/ddt.2026.01051","doi":"https://doi.org/10.5582/ddt.2026.01051","is_oa":true,"landing_page_url":"https://doi.org/10.5582/ddt.2026.01051","pdf_url":"https://www.jstage.jst.go.jp/article/ddt/advpub/0/advpub_2026.01051/_pdf","source":{"id":"https://openalex.org/S2764561415","display_name":"Drug Discoveries & Therapeutics","issn_l":"1881-7831","issn":["1881-7831","1881-784X"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-70","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discoveries & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7202364088.pdf","grobid_xml":"https://content.openalex.org/works/W7202364088.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7204111769","https://openalex.org/W7211971038","https://openalex.org/W7221765207","https://openalex.org/W7202168920","https://openalex.org/W7134978567","https://openalex.org/W7203830056","https://openalex.org/W7222136644","https://openalex.org/W7164171533","https://openalex.org/W7208479309","https://openalex.org/W7153230817"],"abstract_inverted_index":{"Hypercholesterolemia,":[0],"and":[1,18,27,40,63,87,109,117,126,137,170,196],"particularly":[2],"elevated":[3],"low-density":[4],"lipoprotein":[5],"cholesterol":[6],"(LDL-C),":[7],"is":[8,55,93],"a":[9,75,157],"major":[10,193],"causal":[11],"factor":[12],"in":[13,90],"atherosclerotic":[14],"cardiovascular":[15,168,194],"disease":[16],"(ASCVD)":[17],"contributes":[19],"substantially":[20],"to":[21,144,153,175],"coronary":[22],"heart":[23],"disease,":[24],"ischemic":[25],"stroke,":[26],"peripheral":[28],"artery":[29],"disease.":[30],"Statins":[31],"remain":[32],"the":[33,68,84,94,104,121,138],"cornerstone":[34],"of":[35,70],"lipid-lowering":[36],"therapy,":[37],"while":[38],"ezetimibe":[39],"injectable":[41],"proprotein":[42],"convertase":[43],"subtilisin/kexin":[44],"9":[45],"(PCSK9)":[46],"targeted":[47],"agents":[48],"are":[49],"added":[50],"when":[51],"further":[52],"LDL-C":[53,118,133,164,188],"reduction":[54,165,189],"required.":[56],"However,":[57],"concerns":[58],"about":[59],"injections,":[60],"cost,":[61],"accessibility,":[62],"treatment":[64],"inertia":[65],"have":[66],"limited":[67],"use":[69],"existing":[71],"PCSK9":[72,98,108],"therapies,":[73],"creating":[74],"need":[76],"for":[77,142],"potent":[78],"oral":[79,97],"alternatives.":[80],"Enlicitide,":[81],"approved":[82,96],"by":[83,134],"US":[85],"Food":[86],"Drug":[88],"Administration":[89],"July":[91],"2026,":[92],"first":[95],"inhibitor.":[99],"This":[100],"macrocyclic":[101],"peptide":[102],"blocks":[103],"interaction":[105],"between":[106],"circulating":[107],"hepatic":[110],"LDL":[111],"receptors,":[112],"thereby":[113],"increasing":[114],"receptor":[115],"recycling":[116],"clearance.":[119],"In":[120],"phase":[122],"III":[123],"CORALreef":[124,127,181],"Lipids":[125],"HeFH":[128],"trials,":[129],"once-daily":[130],"enlicitide":[131],"reduced":[132],"approximately":[135],"60%,":[136],"effect":[139],"was":[140,173],"maintained":[141],"up":[143],"52":[145],"weeks.":[146],"Adverse":[147],"event":[148],"rates":[149],"were":[150],"generally":[151],"similar":[152],"those":[154,160],"observed":[155],"with":[156],"placebo.":[158],"Nevertheless,":[159],"trials":[161],"primarily":[162],"evaluated":[163],"rather":[166],"than":[167],"outcomes,":[169],"their":[171],"duration":[172],"insufficient":[174],"establish":[176],"long-term":[177,201],"safety.":[178],"The":[179],"ongoing":[180],"Outcomes":[182],"trial":[183],"will":[184,197],"determine":[185],"whether":[186],"enlicitide-mediated":[187],"translates":[190],"into":[191],"fewer":[192],"events":[195],"help":[198],"define":[199],"its":[200],"clinical":[202],"role.":[203]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2026-08-14T00:00:00"}